Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
Schaefer
Werner
W
D001561:Benzilates / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008333:Mandelic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D012449:Safety; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
D001561:Benzilates; D008333:Mandelic Acids; D010276:Parasympatholytics; C015586:propiverine; C005419:oxybutynin